INTANGIBLE ASSETS (Q3) (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2015

Dec. 31, 2014

INTANGIBLE ASSETS [Abstract]

Intangible assets

Intangible assets, net consisted of the following at September 30, 2015 and December 31, 2014:

Intangible assets		September 30, 2015	December 31, 2014
	Patent - Amlexanox (Aphthasol®)	$   2,090,000	$    2,090,000
	Patent - Amlexanox (OraDisc™ A)	6,873,080	6,873,080
	Patent - OraDisc™	73,000	73,000
	Patent - Hydrogel nanoparticle aggregate	589,858	589,858
		9,625,938	9,625,938
	Less: accumulated amortization	( 6,785,634)	(6,430,249)
	Intangible assets, net	$   2,840,304	$   3,195,689

Intangible assets are comprised of patents acquired in October 2005.  Intangible assets, net consisted of the following at December 31:

Intangible assets		2014	2013
	Patent - Amlexanox (Aphthasol®)	$    2,090,000	$    2,090,000
	Patent - Amlexanox (OraDisc™ A)	6,873,080	6,873,080
	Patent - OraDisc™	73,000	73,000
	Patent - Hydrogel nanoparticle aggregate	589,858	589,858
		9,625,938	9,625,938
	Less: accumulated amortization	(6,430,249)	(5,955,101)
	Intangible assets, net	$   3,195,689	$   3,670,837

Future aggregate amortization expense for intangible assets

The future aggregate amortization expense for intangible assets, remaining as of September 30, 2015, is as follows:

Calendar Years		Future Amortization Expense
	2015 (Three months)	$      119,763
	2016	476,450
	2017	475,148
	2018	475,148
	2019	475,148
	2020 & Beyond	818,647
	Total	$   2,840,304

The future aggregate amortization expense for intangible assets, remaining as of December 31, 2014, is as follows:

Calendar Years		Future Amortization Expense
	2015	$    475,148
	2016	476,450
	2017	475,148
	2018	475,148
	2019	475,148
	2020 & Beyond	818,647
	Total	$  3,195,689